Image-01 (Image 01)
Mesalamine Suspension
Product Images NDC 72162-2302
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 72162-2302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-02 (Image 02)
Image-03 (Image 03)
Image-04 (Image 04)
Image-05 (Image 05)
Extended Label (Lbl721622302.1)
This is a set of instructions for a medication stating that one unit-dose suspension should be taken in the evenings before going to bed. It emphasizes for the medication to be dispensed in its original foil-wrapped packaging without repackaging it. Additionally, it mentions that the product contents may darken over time.*
Label (Lbl721622302)
This text is a product description for Mesalamine enema kit containing 4 grams of aminosalicyclic acid in suspension for rectal use. It provides storage instructions, dosage information, and a link for further details. The product is meant for rectal administration only and should be kept out of reach of children due to potential staining of surfaces.*
Str (Str)
This text appears to show chemical structures. The first one is likely a hydrogen atom (H) connected to a nitrogen atom (N), the second one is a carboxylic acid functional group (COOH), and the last one is likely a hydroxyl group (OH). These structures are often seen in organic chemistry.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
